---
title: "Parke Bancorp | 10-Q: FY2025 Q3 Revenue: USD 37.36 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264505506.md"
datetime: "2025-11-05T21:54:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264505506.md)
  - [en](https://longbridge.com/en/news/264505506.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264505506.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/264505506.md) | [繁體中文](https://longbridge.com/zh-HK/news/264505506.md)


# Parke Bancorp | 10-Q: FY2025 Q3 Revenue: USD 37.36 M

Revenue: As of FY2025 Q3, the actual value is USD 37.36 M.

EPS: As of FY2025 Q3, the actual value is USD 0.89.

EBIT: As of FY2025 Q3, the actual value is USD -6.678 M.

### Community Banking Segment

#### Net Interest Income

-   Net interest income for the three months ended September 30, 2025, was $20.2 million, an increase of $5.4 million or 37.0% compared to the same period in 2024.
-   For the nine months ended September 30, 2025, net interest income was $54.6 million, an increase of $11.6 million or 26.8% compared to the same period in 2024.

#### Provision for Credit Losses

-   Provision for credit losses for the three months ended September 30, 2025, was $0.4 million, compared to a recovery of $0.1 million for the same period in 2024.
-   For the nine months ended September 30, 2025, the provision for credit losses was $1.9 million, an increase of $1.4 million compared to the same period in 2024.

#### Non-Interest Income

-   Non-interest income for the three months ended September 30, 2025, was $0.9 million, a decrease of $0.05 million compared to the same period in 2024.
-   For the nine months ended September 30, 2025, non-interest income was $2.5 million, a decrease of $0.7 million compared to the same period in 2024.

#### Non-Interest Expense

-   Non-interest expense for the three months ended September 30, 2025, was $7.2 million, an increase of $0.8 million or 12.6% compared to the same period in 2024.
-   For the nine months ended September 30, 2025, non-interest expense was $20.4 million, an increase of $1.2 million or 6.5% compared to the same period in 2024.

#### Net Income

-   Net income available to common shareholders for the three months ended September 30, 2025, was $10.6 million, an increase of $3.1 million or 41.6% compared to the same period in 2024.
-   For the nine months ended September 30, 2025, net income available to common shareholders was $26.7 million, an increase of $6.6 million or 32.7% compared to the same period in 2024.

#### Cash Flow

-   Net cash provided by operating activities for the nine months ended September 30, 2025, was $25.1 million.
-   Net cash used in investing activities for the nine months ended September 30, 2025, was - $91.6 million.
-   Net cash provided by financing activities for the nine months ended September 30, 2025, was $4.3 million.

#### Future Outlook and Strategy

-   The company focuses on growing customers, loans, deposits, and revenue while improving profitability and managing risk, expenses, and capital.
-   The company aims to maintain capital at an amount commensurate with its risk profile and risk tolerance objectives, meeting both regulatory and market expectations.

#### Unique Metrics

-   Deposit balances from cannabis customers were approximately $225.4 million at September 30, 2025, accounting for 12.9% of total deposits.
-   Cannabis-related loans amounted to $46.1 million at September 30, 2025.

### Related Stocks

- [Parke Bancorp, Inc. (PKBK.US)](https://longbridge.com/en/quote/PKBK.US.md)

## Related News & Research

- [Reminder - Parke Bancorp (PKBK) Goes Ex-Dividend Soon](https://longbridge.com/en/news/281389121.md)
- [UniCredit - as of YE25 group MREL equal to 30.6% of RWA, 10% of LRE](https://longbridge.com/en/news/281399909.md)
- [Wealth First Promoters Confirm 74% Stake With No Encumbrance in FY26](https://longbridge.com/en/news/281530653.md)
- [Cintas (CTAS) Valuation Check After Q3 Results And Higher Fiscal 2026 Guidance](https://longbridge.com/en/news/281225115.md)
- [AngioDynamics Q3 revenue beats estimates on Med Tech strength, raises outlook](https://longbridge.com/en/news/281504186.md)